Clinical efficiency and patient evaluation of digitally manufactured removable complete dentures

ISRCTN ISRCTN21181369
DOI https://doi.org/10.1186/ISRCTN21181369
Secondary identifying numbers 1.1
Submission date
15/05/2021
Registration date
02/06/2021
Last edited
08/07/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Dentures are removable false teeth that fit over the gum and are used to treat tooth loss and replace missing teeth. Complete dentures (CDs) replace all of the upper and/or lower teeth. Dentures can reduce potential problems in speaking and chewing food caused by tooth loss and can have cosmetic benefits that improve patient confidence.

The introduction of computer-aided design & computer-aided manufacturing (CAD/CAM) technology in the field of prosthodontics (dental procedures that involve repairing or replacing teeth with prosthetics such as dentures) has significantly changed the manufacturing methods of CDs. There have not yet been studies to show ifcomputer-aided planning and production of CDs is superior to the conventional procedure.

The aim of this clinical study is to evaluate if digitizing the process of creating complete dentures is beneficial in terms of the precision, appearance, hygienic performance, and long-term behavior of the dentures. The CERAMILL FULL DENTURE PROSTHETICS material systems for CAD/CAM fabrication of complete removable dentures will be investigated and compared to the conventional process of denture fabrication.

Who can participate?
Adult patients with tooth loss requiring a new set of complete dentures who are willing to participate for the duration of the study (approximately 2 years)

What does the study involve?
A total of ten treatment sessions are scheduled at weekly intervals during participation in this study. The first five appointments will include all necessary treatment steps (from initial impression taking to completion) for the fabrication of both conventional and digital complete dentures for each participant. Participants will be allocated to receive dentures fabricated digitally or dentures fabricated using conventional methods in the first half of the study, with an equal chance of being in either group (like tossing a coin). In the second half of the study, participants will receive the denture type that they did not receive in the first half of the study.

The participant will first be given a pair of dentures (digitally or conventionally fabricated) to wear for two weeks and will then be asked to evaluate their quality of life and satisfaction with the dentures using two questionnaires. At the delivery of each denture type, the dentures will be assessed by two experienced clinicians according to defined grading criteria.

After the first 2 week period, participants will return the new dentures and will wear their old dentures for one week so that the denture support tissue returns to its original shape before the second new pair of prostheses is handed over for another two weeks of wear. The participant will then be asked to complete an evaluation of the second pair of prostheses using the quality of life and satisfaction questionnaires and to state the preference for one prosthesis type. Finally, the patient will be able to keep both denture sets and will benefit from the possibility to have a reserve denture set.

What are the possible benefits and risks of participating?
The introduction of CAD/CAM technology in the field of prosthodontics has significantly changed the manufacturing methods of dentures with the aim of accelerating and facilitating everyday clinical practice. The superiority of computer-aided planning and production of complete dentures compared to the conventional procedure, however, has not yet been scientifically proven. In addition, scientific evidence is also lacking regarding clinical effectiveness of digital complete dentures. The purpose of this clinical study is to compare clinical treatment outcomes and patient satisfaction for digitally and conventionally processed CDs with the aim of finding the most proper therapy option for edentulous patients.

Problems are not expected to occur during the study. There are no injury risks or burden to study participants. The low risk is offset by a high benefit of the study. No adverse events are known to date. The potential risk of allergic reactions is very low.

Where is the study run from?
University Clinic of Dentistry, Vienna (Austria)

When is the study starting and how long is it expected to run for?
From September 2018 to September 2021

Who is funding the study?
The University Clinic of Dentistry Vienna, Department of Prosthodontics (Austria)

Who is the main contact?
Dr. dent. med. Lana Zupancic Cepic
lana.zupanciccepic@meduniwien.ac.at

Contact information

Dr Lana Zupancic Cepic
Scientific

Sensengasse 2a
Vienna
1090
Austria

ORCiD logoORCID ID 0000-0003-2379-7043
Phone +4369919238896
Email lana.zupanciccepic@meduniwien.ac.at

Study information

Study designProspective single-blind randomized crossover trial
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use contact email lana.zupanciccepic@meduniwien.ac.at to request a participant information sheet.
Scientific titleComparison of CAD/CAM systems for manufacturing milled removable complete dentures with the conventional technique on clinical efficiency and patient-based outcomes – a prospective crossover study
Study acronymDigital complete dentures
Study hypothesisThe equivalence of expectancies of patient satisfaction scores, oral health-related quality of life represented as Oral Health Impact Profile score (OHIP-20), and clinical efficacy outcomes (i.e. stability, retention, border extension, palatal base thickness, finish quality (polish), aesthetics, phonetics, occlusion, and vertical dimension) for digital versus conventional CDs
Ethics approval(s)Approved 21/06/2018, Ethics Committee of Medical University of Vienna (Borschkegasse, 1090 Wien; +43 1 4040021470; ethik-kom@meduniwien.ac.at), ref: 1062/2018.
ConditionProsthodontic treatment of edentulous patients
InterventionParticipants will be randomized into 3 groups of different digital denture systems (VITA VIONIC, Ceramill FDS, and Baltic Denture) using a 1:1:1 allocation ratio to ensure a balance in sample size across groups. Within each of these three groups patients will be randomized 1:1 into one of the two sequence groups: receiving first the digital and then, after a washout period of one week, the conventional CD or the other way around. The fabrication type of dentures will be blinded to the patient.
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)
Primary outcome measureOral health-related quality of life measured using Oral Health Impact Profile score (OHIP-20) at 2 and 5 weeks
Secondary outcome measures1. Clinical parameters at the time of delivery of the prosthesis including fit, retention, palatal base thickness, denture quality (polish), aesthetics, phonetics, occlusion, and vertical dimension measured and rated by two independent prosthodontists according to defined grading criteria at 0 and 3 weeks
2. Patient denture preference measured using a standardised questionnaire at 5 weeks
Overall study start date01/02/2018
Overall study end date01/09/2022

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants33
Participant inclusion criteria1. Completely edentulous
2. Aged ≥18 years
3. Alveolar ridges Class II, III, or IV according to Cawood and Howell classification
4. Attending the University Clinic of Dentistry Vienna requiring a new set of complete dentures (CD) for the reason of impaired aesthetics and function (for example worn teeth and denture stains) of the existing ones
5. Willing to participate for the duration of the study and provides written informed consent
Participant exclusion criteria1. Severely atrophic ridges (Class V and VI)
2. Hypertrophic tissue
3. Maxillofacial defects
Recruitment start date01/07/2018
Recruitment end date01/07/2022

Locations

Countries of recruitment

  • Austria

Study participating centre

University Clinic of Dentistry Vienna
Sensengasse 2a
Vienna
1090
Austria

Sponsor information

University Clinic of Dentistry Vienna
University/education

Medical University of Vienna
Sensengasse 2a
Vienna
1090
Austria

Phone +43 1 40070 4930
Email eva.piehslinger@meduniwien.ac.at
Website https://www.unizahnklinik-wien.at/en/

Funders

Funder type

University/education

Medizinische Universität Wien
Government organisation / Local government
Alternative name(s)
Medical University of Vienna, MediUni Wien
Location
Austria

Results and Publications

Intention to publish date01/09/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe datasets generated and/or analysed during the current study during this study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol file version v2.0 06/06/2018 08/07/2021 No No

Additional files

ISRCTN21181369_PROTOCOL_v2.0_06June2018.pdf
Uploaded 08/07/2021

Editorial Notes

08/07/2021: Uploaded protocol Version 2.0, 06 June 2018 (not peer reviewed).
27/05/2021: Trial's existence confirmed by the Ethics Committee of Medical University of Vienna.